STRS Ohio’s Relay Therapeutics RLAY Stock Holding History

STRS Ohio’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-800	Closed	-$23K	–	2245
2022 Q1	$23K	Sell	800 -2,300	-74%	-$55.8K	﹤0.01%	2031
2021 Q4	$95K	Hold	3,100	–	–	﹤0.01%	1905
2021 Q3	$97K	Buy	+3,100	New	+$104K	﹤0.01%	1948
2020 Q4	–	Sell	-8,000	Closed	-$340K	–	2259
2020 Q3	$340K	Buy	+8,000	New	+$305K	﹤0.01%	1519

Other funds holding RLAY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

STRS Ohio's RLAY Position: Q2 2022 in Review

STRS Ohio sold out of Relay Therapeutics (RLAY) in Q2 2022, closing a stake of 800 shares — an estimated $23K sold.

STRS Ohio first reported a position in RLAY in Q3 2020 and held it in 4 quarters. The position peaked at $340K in Q3 2020. 148 funds tracked by Wall St. Rank hold RLAY as of Q2 2022.

STRS Ohio reported no remaining Relay Therapeutics position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 800 Relay Therapeutics shares in Q2 2022, an estimated $23K.
STRS Ohio first reported a position in Relay Therapeutics in Q3 2020 and held it in 4 quarters.
STRS Ohio's Relay Therapeutics position peaked at $340K in Q3 2020.
148 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.